We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
(-5.5%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$162M |
| 2 |
Vertiv
VRT
|
+$52.4M |
| 3 |
Palo Alto Networks
PANW
|
+$34.3M |
| 4 |
Waters Corp
WAT
|
+$21.5M |
| 5 |
Pinnacle Financial Partners Inc
PNFP
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$607M |
| 2 |
Apple
AAPL
|
+$186M |
| 3 |
Microsoft
MSFT
|
+$139M |
| 4 |
Meta Platforms (Facebook)
META
|
+$89.6M |
| 5 |
NVIDIA
NVDA
|
+$74.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 10.32% |
| 4 | Industrials | 10.12% |
| 5 | Healthcare | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
AnaptysBio
ANAB
$1.55B
| $1.32M | ﹤0.01% |
23,848
-1,184
| -5% | -$63.7K |
|
2002
Pennant Group
PNTG
$1.48B
| $1.32M | ﹤0.01% |
43,341
-567
| -1% | -$17.5K |
|
|
PLGO
2003
Pelagos Insurance Capital
PLGO
$2.22B
| $1.32M | ﹤0.01% |
69,088
-1,763
| -2% | -$33.7K |
|
2004
C3.ai
AI
$1.4B
| $1.32M | ﹤0.01% |
156,591
-7,841
| -5% | -$84.1K |
|
2005
Grupo Aeroportuario del Sureste
ASR
$8.18B
| $1.31M | ﹤0.01% |
3,911
-31
| -0.8% | -$10.6K |
|
2006
Cable One
CABO
$244M
| $1.31M | ﹤0.01% |
14,405
+290
| +2% | +$28.4K |
|
2007
Harrow
HROW
$1.37B
| $1.31M | ﹤0.01% |
37,190
-315
| -0.8% | -$13.8K |
|
2008
Nuvation Bio
NUVB
$2.29B
| $1.3M | ﹤0.01% |
303,881
-4,308
| -1% | -$24K |
|
2009
Trevi Therapeutics
TRVI
$2.6B
| $1.3M | ﹤0.01% |
109,061
+3,139
| +3% | +$35.1K |
|
2010
iRadimed
IRMD
$1.24B
| $1.3M | ﹤0.01% |
13,503
-89
| -0.7% | -$8.9K |
|
|
RYZ
2011
Ryerson Holding Corp
RYZ
$1.61B
| $1.29M | ﹤0.01% |
57,206
+20,452
| +56% | +$533K |
|
|
MFA
2012
MFA Financial
MFA
$931M
| $1.28M | ﹤0.01% |
133,481
-2,373
| -2% | -$23.4K |
|
2013
Community Trust Bancorp
CTBI
$1.42B
| $1.26M | ﹤0.01% |
20,759
-550
| -3% | -$33.4K |
|
2014
Brown-Forman Class A
BF.A
$13.4B
| $1.26M | ﹤0.01% |
46,985
-1,413
| -3% | -$38.4K |
|
2015
Dole
DOLE
$1.36B
| $1.26M | ﹤0.01% |
88,028
-12,473
| -12% | -$189K |
|
2016
Olema Pharmaceuticals
OLMA
$1.01B
| $1.26M | ﹤0.01% |
84,350
+9,971
| +13% | +$222K |
|
2017
Monte Rosa Therapeutics
GLUE
$1.83B
| $1.26M | ﹤0.01% |
76,408
+14,549
| +24% | +$278K |
|
2018
Daktronics
DAKT
$953M
| $1.26M | ﹤0.01% |
64,266
-1,817
| -3% | -$41.5K |
|
2019
Lifestance Health
LFST
$4.2B
| $1.26M | ﹤0.01% |
197,056
+6,930
| +4% | +$48.2K |
|
2020
Trump Media & Technology Group
DJT
$2.73B
| $1.25M | ﹤0.01% |
135,226
+6,086
| +5% | +$69.9K |
|
2021
Teladoc Health
TDOC
$1.64B
| $1.25M | ﹤0.01% |
229,163
-3,449
| -1% | -$19.4K |
|
2022
EyePoint Inc
EYPT
$1B
| $1.25M | ﹤0.01% |
96,677
+7,632
| +9% | +$114K |
|
2023
Appian
APPN
$2.02B
| $1.24M | ﹤0.01% |
51,627
-16,920
| -25% | -$459K |
|
2024
Lloyds Banking Group
LYG
$87.2B
| $1.24M | ﹤0.01% |
246,091
+15,890
| +7% | +$87.2K |
|
2025
IDT Corp
IDT
$1.69B
| $1.24M | ﹤0.01% |
25,195
-620
| -2% | -$30.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
- RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
- RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
- RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
- RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
- RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.